Prcis: Intraocular pressure (IOP) decreased with age in a population-based study in Nepal, from a mean of 14.1 mm Hg among those 60-64 years old to 13.0 mm Hg among those 80 years old or older.
View Article and Find Full Text PDFPurpose: To assess the diagnostic accuracy of anterior segment OCT (AS-OCT) screening for detecting gonioscopically narrow angles.
Design: Population-based cross-sectional study.
Participants: A stratified random sample of individuals aged ≥ 60 years, selected from a door-to-door census performed in low-lying Nepal.
Background/aims: We aimed to examine risk factors for corneal ulcer in a rural and peri-urban setting in Nepal.
Methods: This population-based matched case-control study was nested in a cluster randomised trial in 24 village development committees in Nepal. Incidence density sampling was used to match incident corneal opacity cases to controls, matching on time of opacity, age, sex and location.
Introduction: Glaucoma is the second leading cause of blindness worldwide. Glaucoma will affect 79.6 million individuals by 2020, according to projections.
View Article and Find Full Text PDFObjective: To report the outcome of Burkhalter opponensplasty using Extensor Indicis Proprius with isolated traumatic low median nerve palsy.
Methods: The prospective study was conducted at the Mayo Hospital, Lahore, from June 2010 to June 2013, and comprised cases of Burkhalter opponensplasty using the Extensor Indicis Proprius to restore thumb opposition in isolated median nerve palsies. All patients had the condition for 16 to 20 months.
Objective: To access the role of bone marrow injection in the management of delayed union and non-union.
Methods: The prospective study was conducted at the Department of Orthopaedic Surgery and Traumatology, Mayo Hospital, Lahore, from January 2012 to December 2013, and comprised patients who had long bone fractures that resulted in delayed or non-union and were treated with bone marrow injections. Aspiration of bone marrow was done from tibial tuberosity and was injected percutaneously at the fracture site.